SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001424884-17-000008
Filing Date
2017-02-28
Accepted
2017-02-28 16:44:39
Documents
56
Period of Report
2016-11-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ON FORM 10-K qbio_10k.htm 10-K 1035216
2 CERTIFICATION OF CEO ex_31.htm EX-31.1 16387
3 CERTIFICATE 2 OF CEO ex_32.htm EX-32.1 6149
  Complete submission text file 0001424884-17-000008.txt   3091598

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT qbio-20161130.xml EX-101.INS 372757
5 XBRL TAXONOMY EXTENSION SCHEMA qbio-20161130.xsd EX-101.SCH 30639
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qbio-20161130_cal.xml EX-101.CAL 37243
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qbio-20161130_def.xml EX-101.DEF 67115
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE qbio-20161130_lab.xml EX-101.LAB 230505
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qbio-20161130_pre.xml EX-101.PRE 177319
Mailing Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022
Business Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-K | Act: 34 | File No.: 000-55535 | Film No.: 17648442
SIC: 2834 Pharmaceutical Preparations